Remote Monitored Systems PLC Pharm 2 Farm Update (8931I)
December 16 2020 - 9:11AM
UK Regulatory
TIDMRMS
RNS Number : 8931I
Remote Monitored Systems PLC
16 December 2020
Certain information contained in this announcement would have
been deemed inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014 until the release of this
announcement.
16 December 2020
Remote Monitored Systems plc ("RMS" or the "Company")
Pharm 2 Farm Update
Remote Monitored Systems plc, announces the following updates in
respect of its wholly owned subsidiary, Pharm2 Farm Limited
("P2F").
Receipt of new production line report
Further to the Company's announcement of Monday 14 December
2020, the Company has now received and reviewed the detailed report
on the new production line. The report indicates certain areas of
the line that require refinement prior to delivery, including the
process by which the machine is adjusted for different input
materials. These adjustments are expected to be completed during
the next week alongside the final component finishing work noted in
the Company's announcement of 11 December 2020.
Delivery of the Lemu mask making machine to Nottingham
In order to accommodate the adjustments noted above Lemu have
advised of a further slight delay to the delivery of the machine.
The finished machine will be ready to depart the manufacturers
premises on 24(th) December 2020, the date of arrival in Nottingham
is not known, the intention is of it being ready to commence
operation by mid-January 2021.
The Company expects to provide a further update on expected
production volumes once the machine has been commission and is
operational in Nottingham.
- ENDS -
ENQUIRIES :
Remote Monitored Systems plc
John Richardson (Executive Director) +44 7751 118916
SP Angel Corporate Finance LLP +44 20 3470 0470
Nominated Adviser and Joint Broker
Stuart Gledhill
Caroline Rowe
Peterhouse Corporate Finance +44 20 7469 0930
Joint Broker
Lucy Williams
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDTFBITMTMBBFM
(END) Dow Jones Newswires
December 16, 2020 09:11 ET (14:11 GMT)
Nanosynth (LSE:NNN)
Historical Stock Chart
From May 2024 to Jun 2024
Nanosynth (LSE:NNN)
Historical Stock Chart
From Jun 2023 to Jun 2024